Cerity Partners LLC grew its holdings in Celsius Holdings, Inc. (NASDAQ:CELH – Free Report) by 6.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 20,003 shares of the company’s stock after purchasing an additional 1,226 shares during the quarter. Cerity Partners LLC’s holdings in Celsius were worth $537,000 as of its most recent filing with the SEC.
Several other large investors also recently made changes to their positions in the business. HM Payson & Co. grew its holdings in Celsius by 122.2% during the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after acquiring an additional 550 shares during the last quarter. S.A. Mason LLC lifted its position in shares of Celsius by 100.0% during the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock worth $37,000 after purchasing an additional 700 shares in the last quarter. GAMMA Investing LLC grew its stake in shares of Celsius by 185.7% during the fourth quarter. GAMMA Investing LLC now owns 1,714 shares of the company’s stock valued at $45,000 after purchasing an additional 1,114 shares during the last quarter. Blue Trust Inc. raised its position in Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company’s stock worth $47,000 after purchasing an additional 441 shares during the last quarter. Finally, Knuff & Co LLC acquired a new position in Celsius during the 4th quarter worth $50,000. Institutional investors own 60.95% of the company’s stock.
Celsius Stock Down 3.1 %
Shares of CELH stock opened at $36.09 on Tuesday. The company has a market capitalization of $9.30 billion, a price-to-earnings ratio of 82.02, a P/E/G ratio of 2.90 and a beta of 1.58. Celsius Holdings, Inc. has a 12-month low of $21.10 and a 12-month high of $98.85. The firm has a fifty day moving average of $31.22 and a 200-day moving average of $29.30.
Wall Street Analyst Weigh In
CELH has been the subject of a number of recent research reports. UBS Group boosted their target price on Celsius from $43.00 to $48.00 and gave the stock a “buy” rating in a research report on Thursday, April 17th. Roth Mkm restated a “buy” rating and set a $38.00 target price on shares of Celsius in a research report on Friday, February 21st. B. Riley reiterated a “buy” rating and set a $49.00 price target (up previously from $44.00) on shares of Celsius in a research report on Friday, February 21st. Piper Sandler increased their price objective on shares of Celsius from $43.00 to $44.00 and gave the company an “overweight” rating in a report on Thursday, April 17th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $42.00 price objective on shares of Celsius in a research note on Thursday, December 26th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $46.47.
View Our Latest Analysis on CELH
Insider Activity at Celsius
In related news, insider Paul H. Storey sold 10,188 shares of the firm’s stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the transaction, the insider now owns 45,297 shares of the company’s stock, valued at approximately $1,167,303.69. This trade represents a 18.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Joyce Russell sold 4,000 shares of Celsius stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total transaction of $113,880.00. Following the completion of the sale, the director now owns 19,106 shares in the company, valued at $543,947.82. The trade was a 17.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by insiders.
Celsius Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- What Does a Stock Split Mean?
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- What is the FTSE 100 index?
- Why Call Option Traders Are Targeting This Dividend ETF Now
- How to Buy Gold Stock and Invest in Gold
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Want to see what other hedge funds are holding CELH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celsius Holdings, Inc. (NASDAQ:CELH – Free Report).
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.